Christopher & Banks Upgraded to Outperform by Zacks (CBK)
Christopher & Banks (NYSE:CBK) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued to investors on Wednesday, StockRatingsNetwork.com reports. The firm currently has a $6.90 target price on the stock. Zacks‘ price objective indicates a potential downside of 5.87% from the stock’s previous close.
Christopher & Banks (NYSE:CBK) traded up 10.89% on Wednesday, hitting $7.33. The stock had a trading volume of 766,315 shares. Christopher & Banks has a 1-year low of $2.70 and a 1-year high of $7.92. The stock has a 50-day moving average of $6.35 and a 200-day moving average of $6.5. The company’s market cap is $266.2 million.
Christopher & Banks (NYSE:CBK) last posted its quarterly earnings results on Tuesday, September 10th. The company reported ($0.01) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.02) by $0.01. The company had revenue of $104.20 million for the quarter, compared to the consensus estimate of $105.40 million. During the same quarter in the prior year, the company posted ($0.06) earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis. Analysts expect that Christopher & Banks will post $0.13 EPS for the current fiscal year.
Separately, analysts at Thomson Reuters/Verus downgraded shares of Christopher & Banks (NYSE:CBK) from a “buy” rating to a “hold” rating in a research note to investors on Monday, August 19th.
One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $7.35.
Christopher & Banks Corporation is a retailer of women’s apparel, which operates retail stores through its wholly owned subsidiaries.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.